Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter McLaughlin

Showing results (61-70 of 116) with videos related to

Pageof 12
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 8, 2003
Stage III follicular lymphoma: long-term follow-up and patterns of failureChul S Ha, Joseph S Kong, Peter McLaughlin, et al.
Leukemia & Lymphoma|July 25, 2013
Clinical value of magnetic resonance imaging and other baseline testing for conjunctival mucosa-associated lymphoid tissue lymphomaQasiem J Nasser, Margaret L Pfeiffer, Jorge Romaguera, et al.
Cancer|November 30, 2006
Experience with heat shock protein-peptide complex 96 vaccine therapy in patients with indolent non-Hodgkin lymphomaYasuhiro Oki, Peter McLaughlin, Luis E Fayad, et al.
British Journal of Haematology|September 4, 2008
Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphomaBarbara Pro, Brian Leber, Mitchell Smith, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 10, 2012
The absolute monocyte and lymphocyte prognostic index for patients with diffuse large B-cell lymphoma who receive R-CHOPNicolas Batty, Elham Ghonimi, Lei Feng, et al.
International Journal of Radiation Oncology, Biology, Physics|August 23, 2005
A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphomaChul S Ha, Fernando Cabanillas, Ming S Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2003
Nonablative allogeneic stem-cell transplantation for advanced/recurrent mantle-cell lymphomaIssa F Khouri, Ming-S Lee, Rima M Saliba, et al.
Cancer|July 23, 2003
A pilot study of rituximab in patients with recurrent, classic Hodgkin diseaseAnas Younes, Jorge Romaguera, Frederick Hagemeister, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2008
Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphomaApostolia-Maria Tsimberidou, Sijin Wen, Peter McLaughlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2010
Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortiumSonali M Smith, Koen van Besien, Theodore Karrison, et al.
Pageof 12

Showing results (61-70 of 116) with videos related to

Sort By:
Pageof 12
International Journal of Radiation Oncology, Biology, Physics|October 8, 2003
Stage III follicular lymphoma: long-term follow-up and patterns of failureChul S Ha, Joseph S Kong, Peter McLaughlin, et al.
Leukemia & Lymphoma|July 25, 2013
Clinical value of magnetic resonance imaging and other baseline testing for conjunctival mucosa-associated lymphoid tissue lymphomaQasiem J Nasser, Margaret L Pfeiffer, Jorge Romaguera, et al.
Cancer|November 30, 2006
Experience with heat shock protein-peptide complex 96 vaccine therapy in patients with indolent non-Hodgkin lymphomaYasuhiro Oki, Peter McLaughlin, Luis E Fayad, et al.
British Journal of Haematology|September 4, 2008
Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphomaBarbara Pro, Brian Leber, Mitchell Smith, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 10, 2012
The absolute monocyte and lymphocyte prognostic index for patients with diffuse large B-cell lymphoma who receive R-CHOPNicolas Batty, Elham Ghonimi, Lei Feng, et al.
International Journal of Radiation Oncology, Biology, Physics|August 23, 2005
A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphomaChul S Ha, Fernando Cabanillas, Ming S Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2003
Nonablative allogeneic stem-cell transplantation for advanced/recurrent mantle-cell lymphomaIssa F Khouri, Ming-S Lee, Rima M Saliba, et al.
Cancer|July 23, 2003
A pilot study of rituximab in patients with recurrent, classic Hodgkin diseaseAnas Younes, Jorge Romaguera, Frederick Hagemeister, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2008
Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphomaApostolia-Maria Tsimberidou, Sijin Wen, Peter McLaughlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2010
Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortiumSonali M Smith, Koen van Besien, Theodore Karrison, et al.
Pageof 12